insights_auto
Why is YP2 down 7.94%?
Dive Deeperchevron_right
YP2:FRA
BioLine RX Ltd - ADR
€1.16
arrow_downward
-7.94%(-0.10) 1D
Nov 13, 10:00:00 PM GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for YP2...
Open
€0.97
High
€1.16
Low
€0.97
Mkt. cap
9.30M
Avg. vol.
50.00
Volume
0.00
52-wk high
€3.26
52-wk low
€0.97
No. of employees
22
Open
€0.97
High
€1.16
Low
€0.97
Mkt. cap
9.30M
Avg. vol.
50.00
Volume
0.00
52-wk high
€3.26
52-wk low
€0.97
No. of employees
22
News stories
From web sources and news partners
KuCoin
·
2 hours ago
Buy when the crowd is scared. The signal: AAII bearish readi
BigGo Finance
·
10 hours ago
Wall Street's Oldest Lesson: Sitting Out the Market Beats Almost Nothing
FXLeaders
·
1 hour ago
Dow Jones and Nasdaq Futures Open Higher as Nvidia Earnings and Anthropic IPOSet the Tone
The Motley Fool
·
8 hours ago
This Dividend King Yields 5 Times the S&P 500. Is It a Buy Now?
Profile
BioLineRx Ltd., or BioLine, is a publicly traded drug development company. Headquartered in Israel, its shares are traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Wikipedia
About BioLine RX Ltd - ADR
CEOPhilip A. Serlin
Employees22
Founded2003
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitebiolinerx.com